Table of Contents

2019-2024 Global Targeted RNA Sequencing Consumption Market Report

1 Scope of the Report

• 1.1 Market Introduction
• 1.2 Research Objectives
• 1.3 Years Considered
• 1.4 Market Research Methodology
• 1.5 Economic Indicators
• 1.6 Currency Considered

2 Executive Summary

• 2.1 World Market Overview
  • 2.1.1 Global Targeted RNA Sequencing Consumption 2014-2024
  • 2.1.2 Targeted RNA Sequencing Consumption CAGR by Region
• 2.2 Targeted RNA Sequencing Segment by Type
  • 2.2.1 enrichment approaches
  • 2.2.2 amplicon-based approaches
• 2.3 Targeted RNA Sequencing Consumption by Type
  • 2.3.1 Global Targeted RNA Sequencing Consumption Market Share by Type (2014-2019)
  • 2.3.2 Global Targeted RNA Sequencing Revenue and Market Share by Type (2014-2019)
  • 2.3.3 Global Targeted RNA Sequencing Sale Price by Type (2014-2019)
• 2.4 Targeted RNA Sequencing Segment by Application
  • 2.4.1 Research Institutes
  • 2.4.2 Hospitals & Clinics
  • 2.4.3 Biotechnology Company
  • 2.4.4 Diagnostic Lab
• 2.5 Targeted RNA Sequencing Consumption by Application
  • 2.5.1 Global Targeted RNA Sequencing Consumption Market Share by Application (2014-2019)
  • 2.5.2 Global Targeted RNA Sequencing Value and Market Share by Application (2014-2019)
  • 2.5.3 Global Targeted RNA Sequencing Sale Price by Application (2014-2019)

3 Global Targeted RNA Sequencing by Players

• 3.1 Global Targeted RNA Sequencing Sales Market Share by Players
  • 3.1.1 Global Targeted RNA Sequencing Sales by Players (2017-2019)
  • 3.1.2 Global Targeted RNA Sequencing Sales Market Share by Players (2017-2019)
• 3.2 Global Targeted RNA Sequencing Revenue Market Share by Players
  • 3.2.1 Global Targeted RNA Sequencing Revenue by Players (2017-2019)
  • 3.2.2 Global Targeted RNA Sequencing Revenue Market Share by Players (2017-2019)
• 3.3 Global Targeted RNA Sequencing Sale Price by Players
• 3.4 Global Targeted RNA Sequencing Manufacturing Base Distribution, Sales Area, Product Types by Players
  • 3.4.1 Global Targeted RNA Sequencing Manufacturing Base Distribution and Sales Area by Players
  • 3.4.2 Players Targeted RNA Sequencing Products Offered
• 3.5 Market Concentration Rate Analysis
  • 3.5.1 Competition Landscape Analysis
  • 3.5.2 Concentration Ratio (CR3, CR5 and CR10) (2017-2019)
• 3.6 New Products and Potential Entrants
• 3.7 Mergers & Acquisitions, Expansion

4 Targeted RNA Sequencing by Regions

• 4.1 Targeted RNA Sequencing by Regions
  • 4.1.1 Global Targeted RNA Sequencing Consumption by Regions
  • 4.1.2 Global Targeted RNA Sequencing Value by Regions
• 4.2 Americas Targeted RNA Sequencing Consumption Growth
• 4.3 APAC Targeted RNA Sequencing Consumption Growth
• 4.4 Europe Targeted RNA Sequencing Consumption Growth
• 4.5 Middle East & Africa Targeted RNA Sequencing Consumption Growth

5 Americas

• 5.1 Americas Targeted RNA Sequencing Consumption by Countries
  • 5.1.1 Americas Targeted RNA Sequencing Consumption by Countries (2014-2019)
  • 5.1.2 Americas Targeted RNA Sequencing Value by Countries (2014-2019)
• 5.2 Americas Targeted RNA Sequencing Consumption by Type
• 5.3 Americas Targeted RNA Sequencing Consumption by Application
• 5.4 United States
• 5.5 Canada
• 5.6 Mexico
• 5.7 Key Economic Indicators of Few Americas Countries

6 APAC

• 6.1 APAC Targeted RNA Sequencing Consumption by Countries
  • 6.1.1 APAC Targeted RNA Sequencing Consumption by Countries (2014-2019)
  • 6.1.2 APAC Targeted RNA Sequencing Value by Countries (2014-2019)
• 6.2 APAC Targeted RNA Sequencing Consumption by Type
• 6.3 APAC Targeted RNA Sequencing Consumption by Application
• 6.4 China
• 6.5 Japan
• 6.6 Korea
• 6.7 Southeast Asia
• 6.8 India
• 6.9 Australia
• 6.10 Key Economic Indicators of Few APAC Countries

7 Europe

• 7.1 Europe Targeted RNA Sequencing by Countries
  • 7.1.1 Europe Targeted RNA Sequencing Consumption by Countries (2014-2019)
  • 7.1.2 Europe Targeted RNA Sequencing Value by Countries (2014-2019)
• 7.2 Europe Targeted RNA Sequencing Consumption by Type
• 7.3 Europe Targeted RNA Sequencing Consumption by Application
• 7.4 Germany
• 7.5 France
• 7.6 UK
• 7.7 Italy
• 7.8 Russia
• 7.9 Spain
• 7.10 Key Economic Indicators of Few Europe Countries

8 Middle East & Africa

• 8.1 Middle East & Africa Targeted RNA Sequencing by Countries
  • 8.1.1 Middle East & Africa Targeted RNA Sequencing Consumption by Countries (2014-2019)
  • 8.1.2 Middle East & Africa Targeted RNA Sequencing Value by Countries (2014-2019)
• 8.2 Middle East & Africa Targeted RNA Sequencing Consumption by Type
• 8.3 Middle East & Africa Targeted RNA Sequencing Consumption by Application
• 8.4 Egypt
• 8.5 South Africa
• 8.6 Israel
• 8.7 Turkey
• 8.8 GCC Countries

9 Market Drivers, Challenges and Trends

• 9.1 Market Drivers and Impact
  • 9.1.1 Growing Demand from Key Regions
  • 9.1.2 Growing Demand from Key Applications and Potential Industries
• 9.2 Market Challenges and Impact
• 9.3 Market Trends

10 Marketing, Distributors and Customer

• 10.1 Sales Channel
  • 10.1.1 Direct Channels
  • 10.1.2 Indirect Channels
• 10.2 Targeted RNA Sequencing Distributors
• 10.3 Targeted RNA Sequencing Customer

11 Global Targeted RNA Sequencing Market Forecast

• 11.1 Global Targeted RNA Sequencing Consumption Forecast (2019-2024)
• 11.2 Global Targeted RNA Sequencing Forecast by Regions
  • 11.2.1 Global Targeted RNA Sequencing Forecast by Regions (2019-2024)
  • 11.2.2 Global Targeted RNA Sequencing Value Forecast by Regions (2019-2024)
  • 11.2.3 Americas Consumption Forecast
  • 11.2.4 APAC Consumption Forecast
  • 11.2.5 Europe Consumption Forecast
  • 11.2.6 Middle East & Africa Consumption Forecast
• 11.3 Americas Forecast by Countries
  • 11.3.1 United States Market Forecast
  • 11.3.2 Canada Market Forecast
  • 11.3.3 Mexico Market Forecast
  • 11.3.4 Brazil Market Forecast
• 11.4 APAC Forecast by Countries
  • 11.4.1 China Market Forecast
  • 11.4.2 Japan Market Forecast
  • 11.4.3 Korea Market Forecast
  • 11.4.4 Southeast Asia Market Forecast
  • 11.4.5 India Market Forecast
  • 11.4.6 Australia Market Forecast
• 11.5 Europe Forecast by Countries
  • 11.5.1 Germany Market Forecast
  • 11.5.2 France Market Forecast
  • 11.5.3 UK Market Forecast
  • 11.5.4 Italy Market Forecast
  • 11.5.5 Russia Market Forecast
  • 11.5.6 Spain Market Forecast
• 11.6 Middle East & Africa Forecast by Countries
  • 11.6.1 Egypt Market Forecast
  • 11.6.2 South Africa Market Forecast
  • 11.6.3 Israel Market Forecast
  • 11.6.4 Turkey Market Forecast
  • 11.6.5 GCC Countries Market Forecast
• 11.7 Global Targeted RNA Sequencing Forecast by Type
• 11.8 Global Targeted RNA Sequencing Forecast by Application

12 Key Players Analysis

• 12.1 Thermo Fisher
  • 12.1.1 Company Details
  • 12.1.2 Targeted RNA Sequencing Product Offered
  • 12.1.3 Thermo Fisher Targeted RNA Sequencing Sales, Revenue, Price and Gross Margin (2017-2019)
  • 12.1.4 Main Business Overview
  • 12.1.5 Thermo Fisher News
• 12.2 Illumina
  • 12.2.1 Company Details
  • 12.2.2 Targeted RNA Sequencing Product Offered
  • 12.2.3 Illumina Targeted RNA Sequencing Sales, Revenue, Price and Gross Margin (2017-2019)
  • 12.2.4 Main Business Overview
  • 12.2.5 Illumina News
• 12.3 Roche Holdings
  • 12.3.1 Company Details
  • 12.3.2 Targeted RNA Sequencing Product Offered
  • 12.3.3 Roche Holdings Targeted RNA Sequencing Sales, Revenue, Price and Gross Margin (2017-2019)
  • 12.3.4 Main Business Overview
  • 12.3.5 Roche Holdings News
• 12.4 BGI
  • 12.4.1 Company Details
  • 12.4.2 Targeted RNA Sequencing Product Offered
  • 12.4.3 BGI Targeted RNA Sequencing Sales, Revenue, Price and Gross Margin (2017-2019)
  • 12.4.4 Main Business Overview
  • 12.4.5 BGI News
• 12.5 Eurofins
  • 12.5.1 Company Details
  • 12.5.2 Targeted RNA Sequencing Product Offered
  • 12.5.3 Eurofins Targeted RNA Sequencing Sales, Revenue, Price and Gross Margin (2017-2019)
  • 12.5.4 Main Business Overview
  • 12.5.5 Eurofins News
• 12.6 LabCorp
  • 12.6.1 Company Details
  • 12.6.2 Targeted RNA Sequencing Product Offered
  • 12.6.3 LabCorp Targeted RNA Sequencing Sales, Revenue, Price and Gross Margin (2017-2019)
  • 12.6.4 Main Business Overview
  • 12.6.5 LabCorp News
• 12.7 Berry Genomics
  • 12.7.1 Company Details
  • 12.7.2 Targeted RNA Sequencing Product Offered
  • 12.7.3 Berry Genomics Targeted RNA Sequencing Sales, Revenue, Price and Gross Margin (2017-2019)
  • 12.7.4 Main Business Overview
  • 12.7.5 Berry Genomics News
• 12.8 Macrogen
  • 12.8.1 Company Details
  • 12.8.2 Targeted RNA Sequencing Product Offered
  • 12.8.3 Macrogen Targeted RNA Sequencing Sales, Revenue, Price and Gross Margin (2017-2019)
  • 12.8.4 Main Business Overview
  • 12.8.5 Macrogen News
• 12.9 GENEWIZ
  • 12.9.1 Company Details
  • 12.9.2 Targeted RNA Sequencing Product Offered
  • 12.9.3 GENEWIZ Targeted RNA Sequencing Sales, Revenue, Price and Gross Margin (2017-2019)
  • 12.9.4 Main Business Overview
  • 12.9.5 GENEWIZ News

13 Research Findings and Conclusion

Targeted RNA-sequencing (RNA-Seq) is a highly accurate method for selecting and sequencing specific transcripts of interest and offers both quantitative and qualitative information. Targeted RNA-Seq can be achieved via either enrichment or amplicon-based approaches, both of which enable gene expression analysis in a focused set of genes of interest, with enrichment assays also providing the ability to detect both known and novel gene fusion partners in many sample types.
Targeted RNA-sequencing (RNA-Seq) is a highly accurate method for selecting and sequencing specific transcripts of interest and offers both quantitative and qualitative information. Targeted RNA-Seq can be achieved via either enrichment or amplicon-based approaches, both of which enable gene expression analysis in a focused set of genes of interest, with enrichment assays also providing the ability to detect both known and novel gene fusion partners in many sample types.
Market competition is not intense. Thermo Fisher, Illumina, Roche Holdings, BGI, Eurofins, etc. are the leaders of the industry, and they hold key technologies and patents, with high-end customers; have been formed in the monopoly position in the industry.

According to this study, over the next five years the Targeted RNA Sequencing market will register a xx% CAGR in terms of revenue, the global market size will reach US$ xx million by 2024, from US$ xx million in 2019. In particular, this report presents the global market share (sales and revenue) of key companies in Targeted RNA Sequencing business, shared in Chapter 3.

This report presents a comprehensive overview, market shares, and growth opportunities of Targeted RNA Sequencing market by product type, application, key manufacturers and key regions and countries.

This study considers the Targeted RNA Sequencing value and volume generated from the sales of the following segments:

Segmentation by product type: breakdown data from 2014 to 2019, in Section 2.3; and forecast to 2024 in section 11.7.
enrichment approaches
amplicon-based approaches
Segmentation by application: breakdown data from 2014 to 2019, in Section 2.4; and forecast to 2024 in section 11.8.
Research Institutes
Hospitals & Clinics
Biotechnology Company
Diagnostic Lab

This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Spain
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report: Breakdown data in in Chapter 3.
Thermo Fisher
Illumina
Roche Holdings
BGI
Eurofins
LabCorp
Berry Genomics
Macrogen
GENEWIZ

In addition, this report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key manufacturers and the market as a whole. It also analyzes key emerging trends and their impact on present and future development.

Research objectives
To study and analyze the global Targeted RNA Sequencing consumption (value & volume) by key regions/countries, product type and application, history data from 2014 to 2018, and forecast to 2024.
To understand the structure of Targeted RNA Sequencing market by identifying its various subsegments.
Focuses on the key global Targeted RNA Sequencing manufacturers, to define, describe and analyze the sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years.
To analyze the Targeted RNA Sequencing with respect to individual growth trends, future prospects, and their contribution to the total market.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
To project the consumption of Targeted RNA Sequencing submarkets, with respect to key regions (along with their respective key countries).
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
To strategically profile the key players and comprehensively analyze their growth strategies.